Kala Bio, Inc. (KALA)
0.569
+0.03
(+5.78%)
USD |
NASDAQ |
Sep 09, 12:39
Kala Bio Price : 0.569 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 0.52 | 0.5464 | 0.4901 | 0.5379 | 175733.0 |
| Sep 04, 2026 | 0.545 | 0.5569 | 0.5006 | 0.5073 | 261359.0 |
| Sep 03, 2026 | 0.5271 | 0.575 | 0.5201 | 0.561 | 577437.0 |
| Sep 02, 2026 | 0.5349 | 0.5652 | 0.503 | 0.5225 | 441116.0 |
| Sep 01, 2026 | 0.5206 | 0.57 | 0.51 | 0.5322 | 9.074M |
| Aug 31, 2026 | 0.6785 | 0.76 | 0.663 | 0.6727 | 239970.0 |
| Aug 28, 2026 | 0.8329 | 1.093 | 0.5867 | 0.6901 | 2.417M |
| Aug 27, 2026 | 0.8011 | 0.85 | 0.8011 | 0.8121 | 32296.00 |
| Aug 26, 2026 | 0.81 | 0.8262 | 0.81 | 0.8161 | 61104.00 |
| Aug 25, 2026 | 0.8399 | 0.8399 | 0.7901 | 0.821 | 21830.00 |
| Aug 24, 2026 | 0.82 | 0.84 | 0.7817 | 0.7954 | 56639.00 |
| Aug 21, 2026 | 0.984 | 0.984 | 0.80 | 0.8201 | 100822.0 |
| Aug 20, 2026 | 0.939 | 0.9585 | 0.8101 | 0.8401 | 64926.00 |
| Aug 19, 2026 | 0.9349 | 0.9399 | 0.89 | 0.90 | 35591.00 |
| Aug 18, 2026 | 0.9001 | 0.9394 | 0.8703 | 0.8987 | 36573.00 |
| Aug 17, 2026 | 0.9499 | 0.9955 | 0.90 | 0.9102 | 117991.0 |
| Aug 14, 2026 | 0.94 | 0.9499 | 0.8768 | 0.9455 | 32179.00 |
| Aug 13, 2026 | 0.971 | 0.971 | 0.8601 | 0.924 | 104220.0 |
| Aug 12, 2026 | 0.897 | 0.95 | 0.819 | 0.884 | 62840.00 |
| Aug 11, 2026 | 0.755 | 0.845 | 0.75 | 0.8449 | 81121.00 |
| Aug 10, 2026 | 0.778 | 0.8186 | 0.7254 | 0.755 | 124514.0 |
| Aug 07, 2026 | 0.7504 | 0.777 | 0.72 | 0.7478 | 43148.00 |
| Aug 06, 2026 | 0.73 | 0.7511 | 0.7065 | 0.7368 | 47718.00 |
| Aug 05, 2026 | 0.75 | 0.7660 | 0.6951 | 0.701 | 40464.00 |
| Aug 04, 2026 | 0.83 | 0.859 | 0.7418 | 0.743 | 127610.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.73 |
| Alnylam Pharmaceuticals, Inc. | 255.71 |
| Anika Therapeutics, Inc. | 20.96 |
| Savara, Inc. | 5.38 |
| Vericel Corp. | 38.82 |
Price Related Metrics
| Price to Book Value | 1.217 |
| Earnings Yield | -12.99K% |
| Market Cap | 11.00M |